Anavex Life Sciences Corp (AVXL)

[chrismiss_everyday]

MDS Virtual Congress 2020

Daniel Weintraub seems to have involvement in a number of sessions. There are plentiful discussions on many of our ongoing speculations such as nutrition, gut composition, etc.

https://www.mdscongress.org/Congress-Branded/Congress-2020-Files/ic20-prelim.pdf

Will Anavex be entering Late-Breaking Abstracts for trials w/ Blarcamesine?

Could Rett Syndrome findings also be presented given the forum’s focus on movement disorders?

“Rhett Syndrome (RS) is one of the best human models to study movement disorders. Patients evolve from a hyperkinetic to a hypokinetic state, and a large series of abnormal movements may be observed along their lives such as stereotypies, tremor, chorea, myoclonus, ataxia, dystonia, and rigidity.“

from: https://pubmed.ncbi.nlm.nih.gov/18512755/

So given our past timeline and present predictions of results being disclosed “mid-year”, maybe we’re in for more than one release of results regarding treatments with 2-73 / Blarcamesine.

Possibility for some reveals.